chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist via another company refers to a female patient of unknown age. On an unknown date approximately in October 2014 (also reported as last week) the patient was vaccinated with MMR II via unknown route (dose and frequency was not reported. It was reported that the patient was breastfeeding at the time she received MMR II last week. No product quality complaint (PQC) was reported. Additional information has been requested.
Climbed stairs 30 min after vaccine given. Developed lightheadedness BP elevated. resolved after 10 minutes.
fever, AMS, +COVID. start zinc, Vit C.  on RA, has elevated WBC ( either UTI or lungs?); on abx. Cr worsening, pt mental status more altered. Nephro consulted, pt straight cath with 700 out. foley placed. started flomax.  noted to be septic with underlying AKI. cultures negtive. No covid symptoms during admission. Dc to nursing home
Throbbing sharp pain, swelling, warmness, shooting pain to fingers, pain with movement.
The flu shot was administered at Pharmacy in the afternoon of Sunday, September 29, 2019. When I went to bed that evening, I felt fine except for the typical soreness at injection site. When I arose the following morning, I noticed a buzzing sensation in the soles of both feet. No pain, just the strange vibration/buzzing feeling. I noticed no inability to walk, bear weight, or otherwise impairment to ambulation. As the week progressed. The sensation gradually became less pronounced and was more intermittent in nature, usually more noticeable in the evening. One week from the beginning of symptoms, I still have buzzing sensation in both feet.
Redness, swelling, abscess & hematoma (baseball sized) noted; Seen by MD 25SEP91 excised, drained of green purulent discharge; Wound packed x 4 by MD; On Duricef had rx for pain;
Patient was given pediatric dose age 5-11 rather than the 12 up dose. Patient was notified age 16 at time of dose
A physician reported the occurrence of screaming episodes in a 4 month old male who received Infanrix for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not specified. The subject experienced no adverse events following his first injection of Infanrix. On 12/10/02, the subject received his second injection of Infanrix (565A9). On the same day, at an unspecified time post-immunization, the subject experienced an episode of screaming lasting more than two hours. The event resolved without medical treatment on 12/10/02.
Streaking from injection site and lymph node swelling in supraclavicular area. Some muscle weakness.
Patient had first Pfizer COVID vaccine on 1/28/2021. She had second Pfizer COVID vaccine on 2/16/2021.
1. discomfort in abdomen, like cramping or feeling of gas. began approx 8 hours after injection ( 4:30 PM ) and lasted through the night. 2. aching in arm and leg joints. began upon rising in morning ---16 hours after injection. 3. soreness at sight continues after 20 hours 4. slight headache at 20 hours                                             Upon rising on 6/3 (40 hours after injection ) most of discomfort in joints has gone.
pt recv vax 2JUN97 & 11JUN97 pt devel chickenpox consisting of less than 50 vesicles, most of which were on trunk;
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 20-FEB-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml VIs 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 27 degrees Fahrenheit (-2.77 degrees Celsius) (lowest recorded temperature) for 1236 hours (sum of hours in excursion). The vaccine status was reported and "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
The day after the vaccine I was tired, sleepy and "groggy".  I went to the toilet and passed out after standing up and turning toward the sink to wash my hands.  My husband (retired internist) heard a thump and found me on the floor.  It took him calling my name 10 times before I woke up.  My pulse was strong and heartbeat regular.   I don't remember being dizzy or lightheaded, only remember going to the toilet and then waking up and wondering why I was lying on the bathroom rug.   I would very much like to know if other people have passed out the day after getting the vaccine.
allergic reaction; hot redness of the size of an orange; five days after receiving her first dose of the Moderna vaccine she experienced got hot, but didn't swell, lasted for 10 days; This spontaneous case was reported by a patient and describes the occurrence of HYPERSENSITIVITY (allergic reaction), VACCINATION SITE ERYTHEMA (hot redness of the size of an orange) and FEELING HOT (five days after receiving her first dose of the Moderna vaccine she experienced got hot, but didn't swell, lasted for 10 days) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event. Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced FEELING HOT (five days after receiving her first dose of the Moderna vaccine she experienced got hot, but didn't swell, lasted for 10 days). On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction) and VACCINATION SITE ERYTHEMA (hot redness of the size of an orange). At the time of the report, HYPERSENSITIVITY (allergic reaction) and VACCINATION SITE ERYTHEMA (hot redness of the size of an orange) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-085334 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Non-Significant F/U AE Info Updates.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085334:2 dose
He got his vaccine, 2 days later he started having pains in the arms.  He went to UC and the lady said that it would go away by itself, and that he may get some headache.  He continues to have pain in his arm.  If he lays on it it feels like a spider web it ripping and it hurts.  If he lays close to a wall it goes away, but if he lays on it it bothers him.  The UC did not give him anything for it, and said it was nothing that they could see.
pt devel a fever 102 & runny nose the day p/vax;no further details were known as of date of this report;
has issue with his face breaking out/with tunnels on face; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Feb2021 (Lot number: EL8982) at the age of 78 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "bitten by a dog when he was 5-6 years old" (unspecified if ongoing), notes: bitten by a dog when he was 5-6 years old; "he had growth on his forehead" (unspecified if ongoing), notes: he had growth on his forehead, it was a blemish and it was thicken up, 3/16th of inch and fell off".; "scar" (unspecified if ongoing), notes: he had a scar and it looked like they took a hotdog; "he had the E-coli" (unspecified if ongoing), notes: Clarified that he had the E-coli 10 years before the vaccine. There were no concomitant medications. The following information was reported: SKIN DISORDER (non-serious) with onset 08Apr2021, outcome "not recovered", described as "has issue with his face breaking out/with tunnels on face". Therapeutic measures were taken as a result of skin disorder.  Additional information: Patient stated that he put alcohol on it which brings round smaller things to the surface so they will fall off. Stated that he takes a washcloth and wipes it off. Stated that he had the Pfizer vaccine dated 13Feb2021 and the next one was 24Feb2021. Stated that his face started breaking out and he went to a dermatologist. Stated that he went to DO/Intern and he said no problem. Stated that his face was breaking out and he has tunnels on his face with stuff coming out. Stated that he has a tunnel on one end and the other end with a tail sticking out. Stated that before the tunnels that he took out something like an arrowhead like a triangle that was big on one end fine on other end and tail on it. Doctor said okay since they were not bleeding. Stated that he never had this problem. Stated. Stated that he put alcohol on it which brings round smaller things to the surface so they will fall off. Stated that he takes a washcloth and wipes it off.   Follow-up attempts are completed. No further information is expected.
pt recvd vax;devel low grade fever p/ immun w/ dtp; 3 days later,devel febrile szs & to er;tx w/ ativan & phenobarbital but devel steven-johnson synd & required hosp;
Mild anaphylaxis less than 5 min after injection. Symptoms onset immediately, including dizziness, rapid heart rate, tightening of the throat, making breathing/swallowing difficult, ears felt strong pressure/itch. Symptoms went away on their own, but several episodes of similar symptoms/intensity persisted throughout the evening roughly every 30min-1hour.
LETHARGIC; SLIGHT HEADACHE; VERY TIRED; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the patient experienced slight headache. On 07-APR-2021, the patient experienced very tired. On 08-APR-2021, the patient experienced lethargic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lethargic, slight headache, and very tired on 08-APR-2021. This report was non-serious. This case, involving the same patient is linked to 20211159512.
Immediately after given the shot, my arm just felt really sore, but 5-10 minutes later my arm felt as though it was going numb, and I was experiencing pain from my neck, chest, and down my back but only on that side where I received the shot. I felt light headed and went to report this to a nurse, and later went to the emergency room.
5-10 minutes after vaccine, pt presented with hives & swelling of the face, spreading to arms and neck rapidly. Pt had a new onset cough with exp. wheezes present upon auscultation.
Swelling, redness and warmth medially and inferrorally to immunization site on RLE. Sx's began 24 hrs post immunization and associated with low grade temp approximately 100 degrees. Pt evaluated in office 48 hrs later, started on Omnicef for possible early cellulitis. Asked to f/u 2-3 d if sx's continue.
Information has been received from a 62 year old female consumer who on 10/10/98 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (manufacturer unknown). Concomitant therapy that same day included a dose of influenza virus vaccine (manufacturer not reported). The patient stated that she was vaccinated with a vaccine for pneumonia and flu (combination pneumonia flu vaccine). She stated that she immediately started to feel ill after taking the medication. She also stated that she died 3 times the following day and had to be revived. She noted that she was hospitalized. Additional information has been requested. Follow up information was received from the patient concerning her experience of sudden death in October 1997 after receiving pneumococcal vaccine 23 polyvalent. The patient had very possible damage to heart a year before from radiation therapy for a small breast tumor that was malignant. The patient naoted that she was also asthmatic. The patient had told her physician that she had problems with flu shots in the past. The patient stated that this experience was ruining my life and that of my families. The patient mentioned two other patients that had heart problems after vaccine. Per 60 day follow up: pt has not recovered. Heart stopped 3 times. Severly damaged.
I couldn?t breath and my blood pressure was abnormally elevated for a prolonged time. It made my  head spinned and pressured. My heart was racing rapidly and feeling fainted
C/O tongue and throat swelling, chest pain 15 minutes after injection; tachy, BP 132/84; Hx of anaphylactic reaction to bee stings.  Carries own epi.  Epi and Benadryl given at 30 minutes after injection.  911 called when pt. reported no change in s/s. Was seen in ER and tx with solumedrol.
Pt received vaccine on 5/28 - presented to the pharmacy today with swelling/redness/heat/ itching  at the site of injection. Pt reported taking tylenol for pain/ swelling. Explained to patient that this looked like a typical injection site reaction and that we would forward the information on. Told patient it would be fine to take benadryl to help with swelling. Encouraged her to come back / follow up with md if it got worse.
Dizziness, problems walking like I am drunk. Vision slightly blurred. No treatment left message with my doctor, his office will be open Monday Nov. 26, 2018,
Wiped out; chills; fever; muscle pain; joint pain; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Wiped out), CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 12-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced MALAISE (Wiped out), CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (injection site pain). At the time of the report, MALAISE (Wiped out), CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (injection site pain) outcome was unknown.            No concomitant medication was provided  No treatment medication was provided
About 2-3 minutes after receiving the vaccine, my throat begin to swell and get itchy. It was a bit hard to swallow. After about 5 minutes my lips were also very itchy.  My husband, who is with me is a nurse/paramedic firefighter so we did leave the CVS once my reaction began as I was embarrassed and didn't want anyone to know. I have an epinephrine inhaler (Primatene mist) that I took two big puffs of, (.25 mg) and 2 bendaryl capsule. After a few minutes the symptoms in my throat/lips etc. went away. I did have hives all over my chest for a few hours after the injection.
Flu vaccine given 10-5-15 to upper (L) shoulder. Continue pain with decreased mobility. Started on NAPROXYN (not effective; now on CELECOXIB and VOLTAREN 1% gel). Have had x-ray's; MRI done 2-4-16...to see ortho MD 2-10-16...
2JUN92 sl discomfort @ inject site which inc in intensity throughout the PM: 3JUN92 redness devel well below inject site w/onset of malaise;
Pt. experience pain of the arm the day following the vaccine administration and still dealing with the pain till now. Patient was given medication and did several test (X ray, Ultrasound) and will follow up the md at end of january 2022. Patient struggles to hold up the arm and pushing off when trying to get off in sitting position.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 41-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Result. Therapeutic measures were taken as a result of covid-19. Clinical course: Anti-viral details: Product: COVID 19 Treatment. Brand: Paxlovid. Treatment start date: 03Jul2022. Treatment stop date: 07Jul2022. Indication: Treatment of COVID-19  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
28 year old patient after receiving the second dose of Pfizer after 20 minutes started to feel a rash on the neck and then the skin turned red on the chest just like the left wrist. At 4:42pm, the patient took half of a Benadryl 25mg and her vitasls were verified which were: 107 pulse, 98 saturation, 120/70 B/P and clear lungs. Patient was kept in observation and later at 4:56pm took the other half of the Benadryl. At 5:10pm, the patient was re-evaluated and the vital signs were: 108 Pulse, 110/80 B/P, 99 saturation and 16 Respiration.
Began experiencing chills approx. twelve hours after receiving the Pfizer booster.   Began running a fever of 102F for 24 hours which then lowered to 100F for another 24 hours.  Total time running fever=48 hours.   Fever broke with intense sweating requiring a change of pajama top.
patient that received the 1st dose of Havrix back in 7/Mar/2023, received the 2nd dose of such vaccine on 7/Jun/2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 19-month-old male patient who received HAV (Havrix) (batch number 2YX23) for prophylaxis.   Concomitant products included HEPATITIS A VACCINE (HAVRIX).   On 07-JUN-2023, the patient received the 2nd dose of Havrix. On 07-JUN-2023, an unknown time after receiving Havrix, the patient experienced drug dose administration interval too short (Verbatim: patient that received the 1st dose of Havrix back in 7/Mar/2023, received the 2nd dose of such vaccine on 7/Jun/2023). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 26-JUL-2023 The vaccine administration facility is the same as primary reporter. The reporter consented to follow up.  The patient received 2nd dose of Havrix earlier than recommended interval, which led to shortening of vaccination schedule.
After my first dose of the Pfizer COVID vaccine I had hemorrhage level vaginal bleeding for four days after the vaccine.  It was a distinct alteration of my normal menstrual cycle and menstrual bleeding.  It was not normal for my body or my menstrual cycle.
Magnet sticking to the injection site and sharp shooting pains/spasms throughtout body
Information has been received from a nurse referring to unspecified patients of unknown age. Patients' drug reaction and medical history were not reported. On unknown dates the patients were vaccinated with VAQTA (lot # K007827 with expiration date 09-DEC-2016 and lot # K005323 with expiration date 10-FEB-2017) (route and dose unknown) which have been exposed to temperature outside of the recommended range). The nurse also reported VAQTA (lot # K007827) exposed to a maximum temperature of 52.28F for cumulative time of 7 hours and 50 minutes and 11 doses with this lot # were administered. There was no concomitant medication reported. No adverse effects were reported. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. No medical history and concurrent conditions were reported. On an unknown date the patients were vaccinated with improperly stored dose of VARIVAX (Merck) (lot # L017146, expiry date 13-MAY-2017), (Lot # L024256, expiry  01-JUL-2017) (dosing regimen and frequency unknown). No concomitant medications were reported. It was reported that there was no previous temperature excursions. It was reported that lot # L017146, expiry date 13-MAY-2017 was exposed to a temperature of 13.2 Fahrenheit (F) for 53 hours and 14 minutes and lot #L024256, expiry date 01-JUL-2017 was exposed to a temperature of 20.3 F for 72 hours. It was reported that this report was reported due to a data logger. No adverse effects were reported. The action taken with the therapy with VARIVAX (Merck) was unknown. The outcome of the event was unknown. There was no product quality complaint reported. It was reported that GARDASIL 9 was supported by prescribing information (details unspecified). This case is linked to case number 1602USA007298 via same reporter link. Additional information has been requested.
Information has been received from a nurse concerning multiple unspecified patients of unknown age and gender. Concurrent condition, concomitant medication and medical history were not provided. On multiple unspecified dates (after 06-OCT-2016), the patients were vaccinated with doses of improperly stored GARDASIL 9 (lot#, expiration date, dose and route were not reported). No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Severe muscle and body aches throughout my body and fatigue.  Tylenol relieved the symptoms but they lasted for 2 days.
Information has been received from a physician concerning a 12 month old patient who was exposed to a woman that developed shingles following subcutaneous vaccination with varicella virus vaccine live (WAES0504USA01512). It was reported that the patient then developed chickenpox. No other information was provided. Additional information has been requested.